- Home
- AQST vs ETON Comparison
AQST vs ETON Comparison
Compare AQST & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- ETON
- Stock Information
- Founded
- AQST 2004
- ETON 2017
- Country
- AQST United States
- ETON United States
- Employees
- AQST 135
- ETON N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- AQST Health Care
- ETON Health Care
- Exchange
- AQST Nasdaq
- ETON Nasdaq
- Market Cap
- AQST 274.4M
- ETON 329.8M
- IPO Year
- AQST 2018
- ETON 2018
- Fundamental
- Price
- AQST $3.01
- ETON $14.51
- Analyst Decision
- AQST Strong Buy
- ETON Strong Buy
- Analyst Count
- AQST 8
- ETON 3
- Target Price
- AQST $10.38
- ETON $24.00
- AVG Volume (30 Days)
- AQST 2.0M
- ETON 330.6K
- Earning Date
- AQST 03-05-2025
- ETON 03-13-2025
- Dividend Yield
- AQST N/A
- ETON N/A
- EPS Growth
- AQST N/A
- ETON N/A
- EPS
- AQST N/A
- ETON N/A
- Revenue
- AQST $58,900,000.00
- ETON $34,677,000.00
- Revenue This Year
- AQST $18.44
- ETON $22.19
- Revenue Next Year
- AQST N/A
- ETON $110.87
- P/E Ratio
- AQST N/A
- ETON N/A
- Revenue Growth
- AQST 22.56
- ETON 5.64
- 52 Week Low
- AQST $2.24
- ETON $3.03
- 52 Week High
- AQST $6.23
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- AQST 43.29
- ETON 41.72
- Support Level
- AQST $2.95
- ETON $14.18
- Resistance Level
- AQST $3.21
- ETON $17.13
- Average True Range (ATR)
- AQST 0.20
- ETON 1.03
- MACD
- AQST 0.02
- ETON -0.50
- Stochastic Oscillator
- AQST 18.42
- ETON 7.80
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.